Tech Company Financing Transactions

Exagen Diagnostics Funding Round

EPIC Ventures, Signal Peak Ventures and Tullis Health Investors joined a $4 million funding round for Exagen Diagnostics. The round was announced on 3/31/2006.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1261 Liberty Way C
Vista, CA 92081
USA

Phone

(888) 452-1522

Website

www.exagen.com

Email Address

[email protected]

Overview

Exagen Diagnostics is a rheumatology specialty company that focuses on the diagnosis, prognosis and monitoring of autoimmune connective tissue disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ron Rocca

        

Chief Financial Officer

Kamal Adawi

        

Chief Medical Officer

Arthur Weinstein

        

Chief Scientific Officer

Thierry Dervieux

        

Vice President

Brian Littlefield

        

Vice President

Tami Powell

        

VP - Finance

Mark Hazeltine

        

VP - Marketing

Brian McEvilly

        

VP - Operations

Claudia Ibarra

        

VP - Sales

John Wegener

        

Browse more venture capital transactions:

Prev: 3/31/2006: Tutor.com venture capital transaction
Next: 3/31/2006: Rapt venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary